Avalo Therapeutics, Inc. (AVTX) Institutional Ownership & Insider Trading
126 institutions reported holding Avalo Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 43 insider trades on Form 4 since 2025-10-01.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AVTXAvalo Therapeutics, Inc.Follow AVTX — free
—
Price chart with a free account
- Market cap
- 371.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Institutions · all 13F filers
quarter to 30 Jun 2026 · filers in both quarters126 institutions held —% of the shares. Across filers that reported both quarters, shares held changed —.
Largest moves, shares (millions)
Institutional flow by quarter
net shares added or trimmed, millions · filers in both quarters| Quarter | Holders | Shares held, M | Change | Increased | New | Decreased | Closed |
|---|---|---|---|---|---|---|---|
| Jun 26 | 126 | 73 | — | — | — | — | — |
| Mar 26 | 97 | 32 | +59.9% | 31 | 28 | 19 | 18 |
| Dec 25 | 84 | 20 | +28.3% | 27 | 29 | 13 | 15 |
| Sep 25 | 66 | 15 | +95.3% | 15 | 32 | 8 | 2 |
| Jun 25 | 36 | 8 | -3.9% | 9 | 4 | 10 | 2 |
| Mar 25 | 34 | 8 | +9.6% | 8 | 5 | 3 | 4 |
| Dec 24 | 33 | 8 | +10.4% | 8 | 6 | 3 | 4 |
| Sep 24 | 29 | 7 | +763.6% | 3 | 9 | 2 | 2 |
Avalo Therapeutics, Inc. — questions
- Who owns Avalo Therapeutics, Inc. stock?
- 126 institutions reported Avalo Therapeutics, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: FMR LLC (9.5%), BlackRock, Inc. (8.1%), Nantahala Capital Management, LLC (6.9%).
- Are Avalo Therapeutics, Inc. insiders buying or selling?
- 43 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.
Every figure on this page comes from Avalo Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.